BRIEF published on 02/09/2026 at 15:42, 4 months 20 days ago The Vanguard Group Discloses Interest in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Vanguard Group Avadel Pharmaceuticals
BRIEF published on 02/09/2026 at 15:42, 4 months 20 days ago Le groupe Vanguard révèle sa participation dans Avadel Pharmaceuticals Groupe Vanguard Formulaire 8.3 Information Sur Les Valeurs Mobilières Avadel Pharmaceuticals Panel Irlandais Des OPA
PRESS RELEASE published on 02/09/2026 at 15:42, 4 months 20 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses 4.93% stake in Just Group plc as of 06 February 2026. Purchase of 18,342 securities at 2.16 GBP per unit disclosed Vanguard Group Financial Disclosure Stake Disclosure Securities Purchase Just Group Plc
PRESS RELEASE published on 02/09/2026 at 15:40, 4 months 20 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.60% stake in Spire Healthcare Group plc. Details of the acquisition include purchases of 1p ordinary shares at 2.03 GBP and 2.04 GBP per unit Financial Transactions The Vanguard Group Stake Disclosure Share Acquisition Spire Healthcare Group Plc
BRIEF published on 02/09/2026 at 15:40, 4 months 20 days ago The Vanguard Group Discloses Position in JTC plc Form 8.3 Takeover Code Vanguard Group Securities Holding JTC Plc
BRIEF published on 02/09/2026 at 15:40, 4 months 20 days ago Le groupe Vanguard révèle sa participation dans JTC plc Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Titres Détenus JTC Plc
PRESS RELEASE published on 02/09/2026 at 15:39, 4 months 20 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.03% interest in Beazley plc through form 8.3. Details of securities owned and recent dealings provided Securities Form 8.3 The Vanguard Group Dealings Beazley Plc
PRESS RELEASE published on 02/09/2026 at 15:37, 4 months 20 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 5.95% stake in Avadel Pharmaceuticals plc as of 06/02/2026. Transactions include purchases and sales of US$0.01 ordinary shares Transactions The Vanguard Group, Inc. Stake Disclosure Avadel Pharmaceuticals Plc US$0.01 Ordinary Shares
PRESS RELEASE published on 02/09/2026 at 15:35, 4 months 20 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.08% stake in JTC plc via Form 8.3 under Rule 8.3 of the Takeover Code Takeover Code Vanguard Group Financial Disclosure Form 8.3 Disclosure JTC Plc
BRIEF published on 02/06/2026 at 15:29, 4 months 23 days ago The Vanguard Group Discloses Stake in NCC Group plc The Vanguard Group Takeover Code Equity Investment Stake Disclosure NCC Group Plc
Published on 06/30/2026 at 14:00, 46 minutes ago Datametrex Announces Completion of AI-Based Evaluation of 2 Patents and Launch of Licensing Initiative
Published on 06/30/2026 at 14:00, 46 minutes ago Star Copper Expands Copper-Gold Portfolio with Two Advanced District-Scale Exploration Assets in British Columbia
Published on 06/30/2026 at 14:00, 46 minutes ago Horizon Aircraft to Report Fourth Quarter 2026 Results and Provide a Business Update on July 16, 2026
Published on 06/30/2026 at 13:30, 1 hour 16 minutes ago Electric Metals Ore Sorting Assessment Indicates Potential to More Than Double Emily Manganese Feed Grade While Recovering 92% of Contained Manganese
Published on 06/30/2026 at 13:08, 1 hour 37 minutes ago Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): Under review
Published on 06/30/2026 at 13:01, 1 hour 44 minutes ago HMS Bergbau AG: Final Figures for Fiscal Year 2025 Published – Significant Earnings Growth and Positive Outlook
Published on 06/30/2026 at 13:00, 1 hour 46 minutes ago Gledhow Investments plc: First Half Results to 31 March 2026
Published on 06/30/2026 at 12:59, 1 hour 47 minutes ago EQS-Adhoc: Emerald Horizon AG: Management Board member and majority shareholder Florian Wagner commits to provide additional equity financing in the amount of EUR 20 million.
Published on 06/30/2026 at 12:35, 2 hours 10 minutes ago Eleving Group S.A. — Acquisition or disposal of the issuer's own shares
Published on 06/30/2026 at 07:30, 7 hours 16 minutes ago Gimv sells its stake in AlpenBlu Clinics (formerly Les Psy Réunis), a Swiss provider of outpatient mental healthcare, to Impact Healthcare.
Published on 06/30/2026 at 07:30, 7 hours 16 minutes ago Gimv cède sa participation dans AlpenBlu Clinics (précédemment Les Psy Réunis), acteur suisse des soins ambulatoires en santé mentale, à Impact Healthcare
Published on 06/30/2026 at 07:00, 7 hours 46 minutes ago bioMérieux submits 510(k) to U.S. FDA for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens
